TargetWoman Condensed Health Information



Hyperhidrosis

This is a medical condition in which the patient sweats excessively and unpredictably, significantly, even when the temperature is cool or when at rest. Caused by over activity of the nervous system, sweating occurs in the hands or armpit and feet. Interestingly, in 40% of Hyperhidrosis patients, other members of the family also suffer from this disorder. The excessive sweating is usually intermittent, and it can also be continuous and usually increases with stress and elevated temperature.


Hyperhidrosis may lead to narrowing of arteries and excessive stimulation of sweat glands and less blood flow to the hands. This makes the person’s hands cold and clammy. The primary symptom of Hyperhidrosis is wetness. Treatments include, administering antiperspirants, medications like anticholinergics drugs, beta blockers – which may cause side effects such as dry mouth, dizziness, and problems with urination.

Iontophoresis is another FDA approved procedure, which uses electricity to temporarily turn off the sweat gland. Botox is another FDA approved treatment for severe underarm sweating, but this treatment can cause temporary weakness and intense pain. Endoscopic thoracic sympathectomy is a minimally invasive surgical procedure and it may be recommended when other treatments fail.

Tags: #Hyperhidrosis
Here is how it works

Enter your health or medical queries in our Artificial Intelligence powered Application here. Our Natural Language Navigational engine knows that words form only the outer superficial layer. The real meaning of the words are deduced from the collection of words, their proximity to each other and the context.

Check all your health queries

Diseases, Symptoms, Tests and Treatment arranged in alphabetical order:

A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z

Popular Topics
Free Health App
Free Android Health App Free WebApp for iPhones


Bibliography / Reference

Collection of Pages - Last revised Date: December 7, 2022